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Sustainable Futures:
Encouraging Risk
Screening of Industrial
Chemicals at the R&D
Stage
U.S. EPA’s Office of
Pollution Preven-

Pesticides and
Pharmaceuticals

tion and Toxics
(OPPT) has devel-

Pesticides are
designed to be toxic

EPA’s P2 Framework

oped computerized
methods for predict-

to specific target organisms in order to

ing the risk of industrial chemical toxic-

control or eliminate
organisms that cre-

ity based on an
analysis of chemical structure. Under the Sustainable Futures Pilot Project, industry is beginning
to realize tangible business and pollution prevention benefits from the use of these methods.
This article discusses the development of the
Sustainable Futures program and highlights
some of the benefits to business, regulators, and
the environment.

Background: Regulation of Chemicals
Three general groups of chemicals are regulated in the United States: pesticides, pharmaceuticals (drugs), and industrial chemicals. The inherent nature of these chemicals varies, as do the
purposes for which they are developed and used.
This has resulted in different approaches to the
regulation of these chemicals.
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ate problems for society (such as rats, roaches, termites, weedy plants,
molds, and other destructive microorganisms).
Pharmaceuticals are also designed to have
specific biological activities; they are used to control or eliminate infectious agents and regulate
physiological functions.
Because pesticides and pharmaceuticals must
possess specific biological activity in order to
function in the desired manner, regulators must
be certain that their use will not result in any undesirable or unintended harm. In order to ensure
public safety, the U.S. Congress passed the Federal
Insecticide, Fungicide and Rodenticide Act of
1972 (FIFRA) to control pesticides. An earlier
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Congress had already adopted the Food, Drug

licly available data, while industrial chemicals are

and Cosmetic Act of 1938 (FDCA) to control
pharmaceuticals.

data-poor.

These laws give regulators of these groups of
chemicals broad and specific authorities. Both
FIFRA and FDCA state that before a chemical can
enter commerce, regulators must receive specific
experimental laboratory data that clearly
demonstrate that the chemical will behave in
the prescribed manner

We all come into contact with industrial
chemicals every day. Industrial chemicals are
used in a very broad array of goods, products, and
services, including (among many others):

tended harm to hu-

•
•

laundry detergents and household cleaners;
fabrics and carpets;

mans or the environ-

•

paper finishes and inks;

ment. A wide range of
specific tests, costing

•
•
•

paints and dyes;
food containers;
personal care products, like hair- and tooth-

and not cause unin-

Unlike pesticides and
pharmaceuticals, industrial
chemicals are not designed to have
specific biological activity.

Industrial Chemicals Can Be Found Nearly
Everywhere

many millions of dollars and multiple
years to complete, are
often required.

EPA’s Office of Pesticide Programs regulates
and controls pesticides, while the U.S. Food and

brushes;
•
•
•

children’s toys;
automobile components; and
computer components.

Drug Administration (FDA) regulates and controls pharmaceuticals.

The fresh scent of your fabric softener, the blue
dye in your jeans, that “new car smell”—all are
the result of industrial chemicals.

Industrial Chemicals

In addition, many solid materials, such as
particleboard in your furniture or your home,

Chemicals that are not pharmaceuticals or
pesticides generally are considered “industrial
chemicals” (except for explosives and radiological
materials). Industrial chemicals serve an incredibly broad range of uses.
Unlike pesticides and pharmaceuticals, industrial chemicals are not designed to have specific biological activity. As a result, no targeted
testing is required before industrial chemicals go
into commerce.

Pesticides and Pharmaceuticals Are DataRich; Industrial Chemicals Are Data-Poor
Because of these different regulatory schemes,
we have different levels of knowledge about the
three groups of regulated chemicals. In general,
pesticides and pharmaceuticals are rich in pub-
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have been produced with industrial chemicals
and may still have these chemicals as critical
components.

The Public Becomes Aware of Industrial
Chemicals
Until the mid-1970s, there were no federal
laws controlling industrial chemicals. Regulation
of these chemicals became a priority in the
United States after the report of some major,
manmade environmental disasters.
One such incident was in the neighborhood
of Love Canal in New York State, where a school
and many homes were built on top of an old industrial dumpsite containing toxic chemicals, including polychlorinated biphenyls (PCBs). An-
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other incident involved the discovery of exten-

and chronic toxicity to fish, birds, and other ter-

sive dioxin contamination of the roads and soils
in Times Beach, Missouri.

restrial species.
These testing requirements mean that a com-

Because of widely reported incidents such as

pany must invest millions of dollars in a chemi-

these, the general public began to recognize
that exposure to some industrial chemicals

cal they wish to bring to market. In addition, EPA

could result in risks to human health and the
environment.

Toxic Substances Control Act: Regulation of
Industrial Chemicals

and FDA typically take years to evaluate test data
submitted with a chemical.
The burden of proof for safety rests squarely
with the company wishing to manufacture or
import pesticides or pharmaceuticals. The company must demonstrate to the regulator that the

In response to these increasing concerns,

chemical is safe for the intended purpose. In ad-

Congress passed the Toxic Substances Control Act
(TSCA) in 1976. This law authorized EPA to con-

dition, the chemical must carry an approved

trol the manufacture, import, use, distribution,
and disposal of industrial chemicals. TSCA is implemented by EPA’s Office of Pollution Preven-

label that clearly states the specifics of use (including dose or application rates) and pro-

tion and Toxics.
TSCA does not require testing of new chemi-

hibitions on use.
The burden of proof
for safety is very differ-

cals, but does require that OPPT review new
chemical submissions within 90 days.

ent for industrial chemicals. Under TSCA,

TSCA Requirements Differ from Those of
FDCA and FIFRA
TSCA is fundamentally different from FIFRA
and FDCA because, as previously discussed, the
nature of the chemicals regulated by each law is
fundamentally different.
Pharmaceuticals and pesticides must be registered with the regulating authority before they
can enter commerce. The registration processes
require that results from specific rigorous human
health toxicity tests be submitted so that the authorities can comprehensively evaluate any potential risks from exposure to the chemical.
Testing may be conducted for carcinogenicity,
reproductive and developmental toxicity, chronic
toxicity, neurotoxicity, mutagenicity, organ toxicity, eye irritation, and skin and/or lung sensitization, among other endpoints. Environmental
testing is also required. This can include testing
on environmental fate and persistence, and acute

Pharmaceuticals and pesticides
must be registered with the
regulating authority before they can
enter commerce.

there is no requirement for chemical
companies to conduct testing of any kind before
commencing manufacture for commercial purposes. The regulatory structure for industrial
chemicals under TSCA differs markedly from that
of drugs and pesticides.

“Existing” versus “New” Chemicals:
Chemicals Are New by Virtue of the Law, Not
Science
Shortly after TSCA was passed in 1976, EPA issued a Federal Register notice asking manufacturers and importers of industrial chemicals to send
notice to the Agency (a postcard was adequate)
listing the names of chemicals they manufactured or imported that were currently in commerce in the United States.
This list of chemicals became the TSCA Inventory of Existing Commercial Chemical Substances. In effect, the TSCA Inventory “grandfa-
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thered” chemicals that were already in commerce

missions must include “all available data on

at the time the Inventory was created. This grandfathering ended when the original TSCA Inven-

chemical identity, production volume, byprod-

tory was completed in 1979. The original Inven-

ucts, use, environmental release, disposal practices, and human exposure.” In addition, the

tory contained approximately 60,000 chemicals.

PMN should include “all existing health and en-

This grandfathering of chemicals in commerce when TSCA was enacted would turn out to

vironmental data in the possession of the sub-

be a major factor contributing to our lack of tox-

mitter, parent company, or affiliates, and a description of any existing data known to or

icity and risk data on chemicals in commerce, because existing chemicals are treated differently

reasonably ascertainable by the submitter.”

from new chemicals under TSCA.

human health and environmental toxicity data
are not readily available to the submitter, and are

EPA Must “Show Cause” to Request Data on
Existing Chemicals

not submitted with the PMN. Submitters are not

Under TSCA, manufacturers and importers are free to use “existing”
chemicals (that is, those included
in the Inventory) for any purpose.

The reality, however, is that most often

required to do any additional specific toxicity

Under TSCA, manufacturers and im-

testing on chemical substances.
OPPT has noticed that typically only a small

porters are free to use
“existing” chemicals

fraction of PMNs contain human health or

(that is, those included
in the Inventory) for
any purpose. No registration or labeling is

needed.
Testing of these existing chemicals is not a condition of manufacture
or use. Under TSCA, EPA can require testing of existing chemicals if the Agency can “show cause”
why testing is necessary, and go through a lengthy
notice-and-comment rulemaking process. The
burden of proof regarding the need for testing is
on EPA and not on the manufacturers/importers/
users of these existing chemicals.

aquatic toxicity data, and endpoints vary. OPPT
staff scientists say that about 15 percent have at
least some mammalian toxicity data, and only 4
percent have repeat dose study data (28- or 90day); less than 5 percent contain aquatic toxicity
data, and about 10 percent have data on physical
chemical properties and/or environmental fate (J.
V. Nabholz, R. Jones—EPA OPPT, April 15, 2004,
personal communication). In addition, the data
submitted quite often are claimed as confidential
and cannot be made publicly available.
The result is that most PMNs, even those that
do contain data, do not contain test data adequate to fully characterize the risks that their
chemicals may pose.

New Chemical Submissions Often Have No
Data

EPA Must Review PMNs, Which Often Lack
Data, in 90 Days

TSCA requires that anyone wishing to commercialize a chemical not already on the Inventory (i.e., a “new” chemical) must submit a Premanufacture Notice (PMN) to EPA OPPT.
As stated on the OPPT New Chemicals Program Web site, http://www.epa.gov/oppt/newchems (as accessed February 19, 2004), PMN sub-

EPA OPPT must complete their assessment of
PMNs and describe any necessary regulatory actions required to control risk within 90 days, although the 90-day clock can be stopped if necessary. OPPT typically regulates or controls about 10
percent of PMNs submitted. One type of regulatory
action is “prescribed use and exposure” controls.
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In the early years of TSCA, few PMNs were

OPPT has databases of information on chemical

submitted to EPA. The number of PMN submis-

PMNs over the past 20-plus years, as well as the
outcome of every chemical review.

sions has steadily increased, however, and EPA
currently receives 1,500 to 2,000 per year. In

While nearest analogue analysis is effective, it

order to deal with the increasing volume, OPPT

is also time-consuming and labor-intensive. As

had to develop a process to essentially “triage”
PMNs. Chemicals known to be low-toxicity—

the volume of PMN submissions increased, the
Agency had to develop additional methods for

and, therefore, low-risk—could be given less

evaluating PMN chemicals in order to remain

scrutiny, allowing EPA scientists to focus on those

within the 90-day time frame allowed by TSCA.

chemicals that may present higher risk.
OPPT developed exemption rules for those

Chemical Categories Approach

chemicals that the Agency believes will not pose a

By the late 1980s, OPPT had enough experi-

risk. Examples of current exemptions are those for:

ence with certain types
of chemicals to be able

•
•

certain polymers;
low-volume and low-exposure chemicals; and

to group them into

•

research and development applications.

OPPT’s Approach to Evaluating Chemicals in
the Absence of Data: Necessity Is the Mother
of Invention
Faced with the challenge of rapidly assessing
many chemicals that most often have no toxicity
data, the Agency developed a stepwise evaluation
process. The steps in this process include nearest
analogue analysis; the chemical categories approach; and computerized predictive methods
known as SARs and QSARs. Each of these is described below.

Nearest Analogue Analysis
Since no data are available for most PMN
chemicals, OPPT uses measured data on structurally related compounds (analogues) to estimate the toxicity of the PMN chemical.
Identification of close analogues requires the
judgment of a highly qualified chemist. OPPT is
fortunate to have experienced, exceptionally wellqualified chemists on staff who spend most of their
time on work related to PMN chemical review.
OPPT staff search previous PMN cases to determine if they have seen this chemical before.

prescribed categories
that share common
characteristics. With
this accumulated expe-

Within a prescribed category, the
toxicity concerns and test
recommendations vary little from
chemical to chemical.

rience, OPPT created
the Chemical Categories Report, available
online at http://www.epa.gov/oppt/newchems/
chemcat.htm. This report has information on
more than 50 classes of chemicals.
Within a prescribed category, the toxicity
concerns and test recommendations vary little
from chemical to chemical. Thus, if a new PMN
chemical is identified as being a member of an established category, the potential health or environmental concerns (or absence of concerns) associated with that category can be attributed to
the chemical.
While this category approach does not include all types of substances, new categories are
added when justified by data and professional
judgment. In addition, this category-based approach has allowed OPPT to share some of its accumulated expertise with the chemical industry
and the general public, even though the underlying data that OPPT used to develop the categories
may be confidential.
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SARs and QSARs: Scientifically Sound
Computational Toxicology Methods
The old adage, “If it walks like a duck, and

Agency is another way of providing access to
EPA’s expertise, as well as permitting indirect use
of confidential data, while still ensuring the pro-

quacks like a duck, it must be a duck” describes
the basis for Structure Activity Relationships

tection of companies’ proprietary interests.

(SARs) and Quantitative Structure Activity Rela-

can make the best use of everyone’s dwindling resources. They can also help avoid unnecessary

tionships (QSARs).

In the long run, these computerized models

Rather than using a tested analogue to predict
the potential toxicity of an untested chemical,

(and increasingly unpopular) animal testing.

SAR and QSAR analyses are based on observations

Outreach Programs Teaching Industry To Use
EPA’s Screening Models: Legacy of the
Pollution Prevention Act

that the properties or toxic activities of a chemical can be associated with a particular descriptor
of the compound, such as molecular shape or
water solubility.
Using
validated
measured data, a regression equation can

OPPT has developed a wide range
of SARs/QSARs for many endpoints,
including both human health and
environmental toxicity.

sometimes be developed that mathematically describes the relationship between the
chemical descriptor
and the property or ac-

tivity. That regression
equation can then be used to predict the properties or toxicity of an untested chemical.
OPPT has developed a wide range of
SARs/QSARs for many endpoints, including
both human health and environmental toxicity.
One of the more widely known OPPT SAR models is ECOSAR (Ecological Structure Activity Relationship), which currently contains the computerized SARs equations for more than 60
chemical classes, as described in the model’s
“Help” functions.
Additional SARs are being programmed into
ECOSAR as resources allow. OPPT is also exploring the development of human health QSARs
that can incorporate the wealth of data received
by the New Chemicals Program.
Development of computerized models constructed using confidential data received by the
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The Pollution Prevention Act (PPA) of 1990
describes basic concepts that, if followed, will
greatly reduce environmental pollution. The PPA
creates a hierarchy of approaches for dealing with
pollution. The Act provides that pollution should
be prevented or reduced at the source if possible.
If this cannot be achieved, waste should be recycled. Disposal or environmental release should
occur only as a last resort. Following passage of
the Act, EPA looked for ways to incorporate these
concepts into Agency programs.
OPPT staff, working within the New Chemicals Program, were aware of a situation commonly encountered when PMN chemicals had to
be regulated. Staff observed that PMN submitters
often could have been alerted to potential toxicity and risk concerns if, during development of
the regulated chemical, the submitter had used
the screening methods that OPPT developed to
screen PMN chemicals.
If a company that is developing a PMN submission realizes that manufacture of its chemical
would result in, for instance, worker inhalation
concerns, the submitter could request certain
worker handling practices in order to eliminate
exposure—and, therefore, risk to workers.
Similarly, if the submitter has five alternative
chemicals which, based on availability and performance, could be used for the desired application, he or she can screen all five candidates and

Maggie Wilson

then select for the PMN the one that has the most
environmentally preferable properties (for example, the chemical that is least toxic to fish).
In these general examples, the PMN submit-

Making EPA Screening Models Available to
Industry Can Benefit Everyone Involved
Giving OPPT risk-screening methods to the

ters would be able to avoid delays resulting from

chemical industry for use at the research and development stage seemed like an idea that could

having the Agency identify toxicity, get back to

be beneficial to everyone. These tools can help in-

the submitter, and require the submitter to add
the controls required to mitigate risk.

dustry identify and take advantage of pollution

The Agency had essentially been telling in-

prevention opportunities even before a chemical
is synthesized. For this reason, OPPT wanted to

dustry, “Send in your chemical and we will tell

make these methods publicly available to encour-

you if it will be allowed.” By the time that OPPT
reviews a PMN, most of the pollution prevention

age risk screening as early as possible in the
chemical development process.

opportunities have already been lost. This situa-

Exhibit 1 illustrates why early prescreening

tion does not encourage the innovation needed
to work toward preventing pollution.

can be so beneficial to industry. As this graphic
shows, companies often do not perform toxicity

Exhibit 1. Chemical R&D Process—Status Quo
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screening until the point at which the PMN is
submitted to EPA. If the company discovers at
this stage that its chemical poses toxicity concerns, it will already have spent considerable time
and resources on the development process—and
may have missed opportunities to consider alternatives or mitigate the toxicity threat.
Initial reactions to EPA’s outreach efforts were
predictable. Within the Agency, some expressed
the belief that it was wrong to give industry

Can the Technology Be Successfully
Transferred?
OPPT wanted to conduct a small pilot project
to learn whether the risk-screening methods used
during the review of new chemicals could be successfully transferred to the chemical industry.

Kodak Pilot Project
EPA and Eastman Kodak reached an agree-

OPPT methods. After all, we would be using

ment to form a partnership for a pilot project.
After giving Kodak the screening models, OPPT

those same methods to review industry chemi-

met with Kodak technical staff several times to

cals. To some, this was seen as giving the fox the

help them understand the model limitations,
practice using the models, and interpret the

key to the henhouse!
In addition, some
developers

model results.
Kodak and OPPT collaborated on a series of

were at first reluctant
to hand out their models because the models

test cases running the models. Kodak gave OPPT
a set of chemicals, and then both Kodak and
OPPT evaluated the chemicals independently

were not well documented and had no

using OPPT screening models.

method

Within the Agency, some expressed
the belief that it was wrong to give
industry OPPT methods.

users’ guide. Others
wanted to enhance
their model by adding additional data.
EPA finally determined that, although the

When Kodak and OPPT met to compare
screening results, everyone was gratified to see
that the model results from the separate evaluations were almost identical. Kodak continues

models may not have been perfect, they could be
tremendously useful to chemical manufacturers,

to use these screening methods after incorporating them into their chemical product development process.

formulators, and users by providing screeninglevel toxicity and risk information that was not

The P2 Framework Is Born

otherwise readily available.
Giving chemical developers additional methods to predict toxicity and risk very early in research and development could maximize pollution prevention opportunities, and would lead to
the development of safer chemicals. This is pollution prevention (often called P2) in its most
basic form.
Industry’s initial reaction to this new cooperative effort was understandable: Here comes the
regulator with his hand out, saying “Show me
your chemicals and I can help you!” Industry
was cautious.
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Based on the highly successful Kodak pilot
project, OPPT combined their chemical toxicity
and risk screening models into the Pollution Prevention (P2) Framework. OPPT then developed
an aggressive outreach program offering seminars
and workshops on the use, interpretation, and
limitations of the P2 Framework models.
I was fortunate to be offered the task of developing the documentation for this outreach effort.
Working with EPA subject matter experts, I put
together the P2 Framework Manual, which is now
available for downloading on the P2 Framework
Web site at http://www.epa.gov/oppt/p2frame-

Maggie Wilson

work. The manual describes each of the models,

The cost accounting study was conducted by

explains how they are used to estimate toxicity
and risk, and includes several case studies showing how the model results are used to predict po-

the Tellus Institute, who worked with Kodak to
compare and document new chemical product

tential risk.

corporating the P2 Framework models.

Project XL Initiatives from Two P2
Framework Partners

The Tellus Institute Kodak case study1 documented how the P2 Framework screening models
gave Kodak a competitive advantage and helped

development at Kodak both before and after in-

Not long after OPPT released the P2 Frame-

them increase profits. The case study held a pow-

work, EPA launched Project XL, an initiative
aimed at improving approaches to pollution pre-

erful message that all business managers would

vention. Project XL (standing for eXcellence and

readily understand: Prescreening chemicals for
toxicity and risk potential at the research and de-

Leadership) was open to anyone—including

velopment stage improves the bottom line.

chemical companies, utilities, and manufacturing
facilities—in all business sectors. Information on
Project XL is available at http://www.epa.gov/

PPG Industries Validates Aquatic Toxicity
SARs in the P2 Framework

projectxl/.
Project XL invited stakeholders to suggest innovative new ways to prevent or reduce pollution. Companies interested in participating submitted proposals to EPA describing their ideas. If
the proposal was accepted, the participant could
qualify for regulatory relief.
Two companies who were partnering with
OPPT to learn how to use the P2 Framework models, Eastman Kodak and PPG Industries, submitted Project XL proposals based on using the models to screen chemicals at the research and
development stage.

Kodak Documents Economic and Business
Benefits from Using the P2 Framework
As documented in Kodak’s Project XL proposal, the company incorporated the P2 Framework into their research and development
process. Kodak shared their experience using the
P2 Framework with others in the industry
through publications and presentations at conferences and meetings. They also conducted a
cost accounting study to describe the economic
and business benefits of applying risk screening
in research and development.

PPG Industries, a major manufacturer of
paints, coatings, glass, and fine chemicals, also
submitted a Project XL proposal based on use of
the P2 Framework. Like Kodak, PPG planned to
incorporate the P2
Framework into their
product development
efforts and share their
experience using the
Framework. In addi-

Project XL invited stakeholders to
suggest innovative new ways to
prevent or reduce pollution.

tion, PPG conducted
an independent validation of ECOSAR.
PPG had previously submitted several dozen
chemicals to both OPPT and Environment
Canada, which requires the submission of test
data with new chemical notifications. PPG compared the aquatic toxicity test data submitted to
Canada against the ECOSAR predictions for
these chemicals. They concluded that ECOSAR
SARs were 87 to 90 percent accurate when compared to test data.2

Regulatory Relief Was a Secondary Benefit
Kodak and PPG were eligible for regulatory relief under Project XL. Both companies asked that
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the usual 90-day review period be shortened to 45
days for submissions developed using the P2
Framework models under their Project XL proposals. EPA agreed, and allowed Kodak and PPG
to submit a Project XL chemical as both a PMN
and a TME (Test Market Exemption), something
not ordinarily allowed under TSCA.

a model that will be widely available to industry,
easy to use and interpret, and helpful in identifying potentially persistent, bioaccumulative, and
toxic chemicals.
There is general agreement that the chemicals of greatest concern are toxics that persist in

The benefit of the simultaneous submissions

the environment and bioconcentrate in living
organisms. Chemicals that have all three of

was that when the prescreened low-toxicity/lowrisk chemical was dropped from review at day 45,

these properties are known as PBTs. They include DDT, PCBs, and dioxin. PBTs are responsi-

the company could begin manufacture immedi-

ble for some of the worst environmental con-

ately, as was customary for a TME, instead of hav-

tamination in communities like Times Beach
and Love Canal.

ing to wait until the conclusion of the usual 90day PMN period.
Both XL projects
ran for three years. It

The chemicals of greatest concern
are toxics that persist in the
environment and bioconcentrate in
living organisms.

was very interesting to
note that PPG took advantage of the expe-

Using the PBT Profiler
The PBT Profiler evaluates a chemical’s structure for potential PBT properties. Users can access
the model at no charge at http://www.pbtprofiler.net. By entering a chemical’s CAS Registry

dited review only
rarely, and Kodak

Number, they can obtain:

never used the regulatory relief. Kodak

•

information on the chemical’s potential PBT
characteristics;

stated that the option
for regulatory relief was appealing. However, the

•

a comparison of the Profiler’s predictions
against the EPA New Chemical Program criteria for persistence, bioaccumulation, and

most significant benefits they gained came from
reduced product development costs, decreased
waste generation, reduced regulatory liability,
and the capacity to deliver products to the customer on schedule.

The PBT Profiler: The P2 Framework’s Next
Generation
In the process of working with industry and
helping them learn to use the P2 Framework
models, OPPT learned that many companies (especially small companies) cannot afford to hire
chemists/toxicologists and get them trained in
the proper use of screening models.
Partly in response to this, OPPT developed the
PBT Profiler from components of the P2 Framework. The Profiler represents an effort to develop
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toxicity;
•
•

information on environmental fate; and
information on “P2 considerations” to assist
in risk management of the chemical.

Input from Industry
Extensive effort was invested in development
of the PBT Profiler model. One factor contributing to its acceptance and wide use is that the
principal users (specifically, members of the
chemical industry) worked with EPA very early in
the development process.
The American Chemistry Council, the Synthetic Organic Chemical Manufacturers Association, and leading chemical manufacturers,
with assistance from Environmental Defense,

Maggie Wilson

collaborated with EPA in developing the PBT
Profiler.

Qualifying for Regulatory Relief Under
Sustainable Futures
In order to qualify for regulatory relief in the

Sustainable Futures: EPA Scales Up the
Successful P2 Framework XL Projects
The Agency was very pleased with the results

form of expedited PMN review, Sustainable Futures participants must demonstrate their competence in using the P2 Framework. In order to do

of the Kodak and PPG Project XL initiatives. As a
result, the Agency decided to “scale up” the con-

this, companies need to:

cepts and offer the program nationally so that

•

take the necessary training;

any company that prescreened new chemical

•

apply the P2 Framework and demonstrate to

submissions could get regulatory relief.
On December 11, 2002, OPPT announced

EPA that this information helped guide decision-making regarding their PMN submis-

the Sustainable Futures Pilot Project in a Federal
Register notice, which is available at http://
www.epa.gov/fedrgstr/EPA-TOX/2002/December/
Day-11/t31243.pdf. “Sustainable Futures” is the
name that has been given to the programmatic
structure developed by OPPT to make the benefits
of using the P2 Framework risk-screening methods available nationwide.

Benefits of Sustainable Futures
Under Sustainable Futures, OPPT is offering
the same form of regulatory relief to qualifying

sion; and
•

submit five to ten successful (i.e., not regulated by EPA)
PMNs that they developed using the
P2 Framework.

OPPT will continue to independ-

By prescreening chemicals,
companies can identify problematic
substances and search for safer
alternatives.

ently evaluate each
Sustainable Futures
PMN submitted.

participants that was offered to Kodak and PPG
under their Project XL agreements—that is, sub-

Working Collaboratively with Business

mission of the chemical substance as both a PMN
and a TME. By submitting a low-toxicity/low-risk

Sustainable Futures is an effective forum for
the Agency and industry to work collaboratively

chemical under Sustainable Futures, the company can potentially go to manufacture at 45
days instead of 90, thus cutting the review time
in half.
The Sustainable Futures Pilot Project offers
participating companies:

toward the shared goals of pollution prevention,
risk reduction, environmental stewardship, and
sustainability.
Companies can gain significant benefits from
prescreening new industrial chemicals using the
same models that EPA will use to review the same
chemical. Doing so allows users to identify potential chemical toxicity, exposure issues, and ultimate risk problems even before the chemical is
synthesized.
By prescreening chemicals, companies can
identify problematic substances and search for
safer alternatives. If no substitute can be found
for a specific chemical, the company will have an

•
•
•
•
•

access to the P2 Framework and PBT Profiler
models;
hands-on training with Agency experts;
one-on-one detailed technical assistance;
regulatory relief for qualifying new chemicals
(as described above); and
a small business assistance program.
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“early warning” about the risk concerns that need
to be mitigated. Including mitigation information in the PMN submission can greatly speed
time to market.

dently estimate when production of the chemical
could begin. Kodak could now tell a client more
precisely when they could deliver the new chemical. This represented a significant business advantage over their competitors.

Lessons Learned from Working with Industry
•

Business Benefits of Prescreening Chemicals
In the process of working cooperatively with
industry and helping them use the Agency’s
screening models, OPPT has learned that the great-

Reduction in Product Development Costs
This benefit was also documented by the Tel-

lus Institute report on Kodak’s experience. Being
able to determine whether a particular chemical
might create concerns greatly reduced the costs

est potential benefits to companies may not come

required to identify successful candidate chemi-

from expedited review. Instead, participating com-

cals and processes and bring new chemical products to market.

panies state that they perceive the greatest benefits
to be factors such as
greater business cer-

Kodak found that prescreening
chemicals at the R&D stage provided greater business certainty.

tainty, reduced product
development costs, decreased waste generation, increased innovation, and enhanced
profits.
All of these factors

combine to give participating companies a competitive advantage over those that do not prescreen chemicals at the research and development stage. OPPT became aware of several of
these potential benefits while working with
Kodak and PPG on their Project XL initiatives.
Some key business benefits are highlighted briefly
below.

•

Business Certainty

Kodak found that prescreening chemicals at
the R&D stage provided greater business certainty, as documented by the Tellus Institute in
its previously described case study.
Using the P2 Framework to prescreen PMNs
allowed Kodak to predict the concerns the
Agency might have when the PMN was finally
submitted for review. This decreased regulatory
uncertainty and allowed Kodak to more confi-
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•

Increased Innovation

Using chemical risk prescreening models facilitates increased innovation because it allows
the submitting company to consider many more
chemical alternatives. This increases their
chances of identifying a chemical with better performance characteristics, or one that is more environmentally preferable, in addition to decreasing the probability of regulation.

•

Increased Profit

The factors described above can all contribute
to increased profits for companies that use chemical risk prescreening models. In addition, these
companies’ profits can be enhanced further
through the intangible (but invaluable) positive
public relations benefits they realize by prescreening chemical alternatives at the research
and development stage.

•

Competitive Advantage

Overall competitive advantage is the major
benefit that is being realized by forward-thinking
companies that are incorporating product stewardship methods (including prescreening of
chemicals using the P2 Framework methods) into
their operations.

Maggie Wilson

Some Technologies Were Not as Transferable
as Hoped
The Agency is learning many additional valu-

This is especially true of the PBT Profiler.
Major chemical companies, including SC Johnson and Bayer, are using the PBT Profiler to

able lessons during the outreach efforts to industry that have culminated in the Sustainable Fu-

screen many chemicals in order to pinpoint

tures Pilot Project. One major lesson is that these

most environmentally preferable chemical alternative.

methods have sometimes not been as transferable
as OPPT had hoped.
An example is the critical step of selecting a

those that may have concerns, or to identify the

Like all screening models, the P2 Framework

close analogue for a chemical that lacks data. Ac-

and PBT Profiler have conservative defaults. They
are best used to prioritize chemicals and identify

curately selecting a close analogue requires many

potentially problematic chemicals for more de-

years of experience in chemistry and toxicology.
OPPT has highly skilled and experienced scien-

tailed evaluation.

tists who have focused their careers on reviewing

Conclusion: A Win-Win-Win Outcome for
Industry, EPA, and the Environment

toxicity studies and data, and gaining a sufficient
knowledge of toxic modes to be able to predict
how a chemical structure will control the ultimate toxicity of that chemical.
Toxicologists with chemical companies often
have many functions, and cannot focus on becoming expert in selecting analogues. OPPT is ex-

The Sustainable Futures Pilot Project has been
a rewarding outreach effort. It has successfully
demonstrated that cooperative efforts can result
in the greatest benefits for everyone involved.
This is truly a “win-win-win” situation.
The chemical industry wins by increasing

ploring methods of capturing the hard-earned,
valuable expertise of its toxicologists and making

profits and gaining competitive advantage.
EPA wins by advancing its pollution preven-

this available to industry.

tion and risk reduction goals.
Most importantly, the environment wins because safer chemicals and processes are entering

Models Are Applicable to Both New and
Existing Chemicals
The chemical risk-screening models that
OPPT developed to screen new chemicals submitted under TSCA are also being applied to existing chemicals. As discussed previously, most
existing chemicals in commerce lack the publicly available data needed to adequately assess
their risk.
Now the OPPT screening models that have become the focus of Sustainable Futures are being
used to screen groups of existing chemicals as
well. This allows the model users to identify existing chemicals that may pose concerns. It also
allows users to prioritize those chemicals that
should be evaluated first, or in greatest detail.

commerce.

For More Information
Additional information on Sustainable Futures is available at http://www.epa.gov/opptintr/
newchems/sustainablefutures.htm.
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